Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Beigene, Gracell, Innovation, Innovent, Moderna, Qilu, Russian Direct Investment Fund, Sesen.